TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals-Reference-Cited by-同舟云学术

TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals

Published:2018-07-04 Issue:44 Volume:37 Page:5901-5912
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Bai Jian,Yeh Shuyuan,Qiu Xiaofu,Hu Linyi,Zeng Jun,Cai Yangke,Zuo Li,Li Gonghui,Yang Guosheng,Chang Chawnshang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0269-1.pdf

Reference46 articles.

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA. 2013;63:11–30.

2. Compérat E, Camparo P. Histological classification of malignant renal tumours at a time of major diagnostic and therapeutic changes. Diagn Interv Imaging. 2012;93:221–31.

3. Stadler W. Targeted agents for the treatment of advanced renal cell carcinoma. Cancer. 2005;104:2323–33.

4. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe’er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739–52.

5. Zhou L, Chang Y, Xu L, Liu Z, Fu Q, Yang Y, et al. The presence of vascular mimicry predicts high risk of clear cell renal cell carcinoma after radical nephrectomy. J Urol. 2016;196:335–42.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma;Current Cancer Drug Targets;2024-10

2. Integrated genomic and proteomic analyses identify PYGL as a novel experimental therapeutic target for clear cell renal cell carcinoma;Heliyon;2024-03

3. Therapeutic potential of vasculogenic mimicry in urological tumors;Frontiers in Oncology;2023-09-21

4. L1CAM promotes vasculogenic mimicry formation by miR‐143‐3p‐induced expression of hexokinase 2 in glioma;Molecular Oncology;2023-02-08

5. Targeting the TR4-induced RCC cells-derived exosomally initiated signaling increases Sunitinib efficacy;2022-12-11